RENAISSANCE TECHNOLOGIES LLC

Position in PVLA — Palvella Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in PVLA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,140,721

+$5,900,761 QoQ

Shares Held

53,270

+196.4% QoQ

Ownership

0.370%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#41

of 197 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. PVLA ranks #57 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,140,721	53,270	+196.4%	Shares	Sole	2026-08-13
2026-03-31	$2,239,960	17,970	-20.2%	Shares	Sole	2026-05-14
2025-12-31	$2,358,215	22,530	-74.9%	Shares	Sole	2026-02-12
2025-09-30	$5,623,104	89,697	+34.2%	Shares	Sole	2025-11-13
2025-06-30	$1,506,979	66,858	+338.2%	Shares	Sole	2025-08-13
2025-03-31	$427,071	15,258	-28.6%	Shares	Sole	2025-05-14
2024-12-31	$256,452	21,371	—	Shares	Sole	2025-02-13
2024-09-30 PIRS	—	32,171	+180.5%	Shares	Sole	2024-11-13
2024-06-30 PIRS	—	11,471	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.